The DOI matches its Crossref record; 307 of the 307 references it cites were found in a registry or an index.
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zuco, V., Cesare, M. D., Cincinelli, R., Nannei, R., Pisano, C., Zaffaroni, N., & Zunino, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029085 · Cited by 67
RetractedAngiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
The growing impact of click chemistry on drug discovery
Kolb, H. C., & Sharpless, K. B. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02933-7 · Cited by 3,716
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Flavonoids: a review of probable mechanisms of action and potential applications
Nijveldt, R. J., van Nood, E., van Hoorn, D. E., Boelens, P. G., van Norren, K., & van Leeuwen, P. A. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.418 · Cited by 3,075
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
The pharmacological basis of therapeutics
Frank, A. L. (1981) · Environmental Research · doi:10.1016/0013-9351(81)90176-6 · Cited by 2,734
Quadruplex DNA: sequence, topology and structure
Burge, S., Parkinson, G. N., Hazel, P., Todd, A. K., & Neidle, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl655 · Cited by 2,408
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
The Pharmacological Basis of Therapeutics
Goodman, L., & Gilhan, A. (1941) · Anesthesiology · doi:10.1097/00000542-194105000-00013 · Cited by 2,146
Plants as a source of anti-cancer agents
Cragg, G. M., & Newman, D. J. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.05.011 · Cited by 2,034
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
Cobb, M. H., & Goldsmith, E. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.14843 · Cited by 1,719
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes
Viegas-Junior, C., Barreiro, E. J., & Fraga, C. A. M. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058805 · Cited by 1,302
Fisher, B., Costantino, J. P., Redmond, C. K., Fisher, E. R., Wickerham, D. L., Cronin, W. M., & Contributors, O. N. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.7.527 · Cited by 1,268
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Designed Multiple Ligands. An Emerging Drug Discovery Paradigm
Morphy, R., & Rankovic, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,209
Sawyers, C. (2004) · Nature · doi:10.1038/nature03095 · Cited by 1,165
HDAC family: What are the cancer relevant targets?
Witt, O., Deubzer, H. E., Milde, T., & Oehme, I. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.016 · Cited by 1,069
Mitochondrial Membrane Potential in Living Cells
Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,037
Plant Foods and Herbal Sources of Resveratrol
Burns, J., Yokota, T., Ashihara, H., Lean, M. E. J., & Crozier, A. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0112973 · Cited by 993
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 970
Hoult, J. R. S., & Payá, M. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02112-4 · Cited by 951
Etoposide: four decades of development of a topoisomerase II inhibitor
Hande, K. R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00228-7 · Cited by 949
Patel, D. J., Phan, A. T., & Kuryavyi, V. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm711 · Cited by 882
Hsiang, Y. H., & Liu, L. F. (1988) · PubMed · Cited by 841
A hitchhiker's guide to G-quadruplex ligands
Monchaud, D., & Teulade-Fichou, M.-P. (2008) · Org. Biomol. Chem. · doi:10.1039/b714772b · Cited by 788
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
Pettit, G. R., Singh, S. B., Hamel, E., Lin, C. M., Alberts, D. S., & Garcia-Kendal, D. (1989) · Experientia · doi:10.1007/bf01954881 · Cited by 786
The Wide Pharmacological Versatility of Semicarbazones, Thiosemicarbazones and Their Metal Complexes
(2004) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557043487484 · Cited by 777
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748
Structural basis for the regulation of tubulin by vinblastine
Gigant, B., Wang, C., Ravelli, R. B. G., Roussi, F., Steinmetz, M. O., Curmi, P. A., Sobel, A., & Knossow, M. (2005) · Nature · doi:10.1038/nature03566 · Cited by 734
From magic bullets to designed multiple ligands
Morphy, R., Kay, C., & Rankovic, Z. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03163-0 · Cited by 729
Kapoor, T. M., Mayer, T. U., Coughlin, M. L., & Mitchison, T. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.975 · Cited by 717
Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T., & Nakanishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4592 · Cited by 694
The multifaceted roles of nitric oxide in cancer
Wink, D. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.711 · Cited by 682 · cited 1×
“Numerous reports on the mediation of cytotoxic effects of metabolic NO release [51e54] such as (i) prevention of metastasis by NO assisting macrophage to kill tumor cells [55] ii) significant potential of NONSAID derivatives such as NCX4040 and ketoprofen-NO hybrids towards the growth inhibition of cancer cells [56] (…”
BackgroundTubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
Jordan, A., Hadfield, J. A., Lawrence, N. J., & McGown, A. T. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u · Cited by 673
Biochemical Mechanisms of Cisplatin Cytotoxicity
Cepeda, V., Fuertes, M. A., Castilla, J., Alonso, C., Quevedo, C., & Perez, J. M. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007779314044 · Cited by 649
Anstead, G. M., Carlson, K. E., & Katzenellenbogen, J. A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00242-5 · Cited by 627
Multi-targeted therapy of cancer by genistein
Banerjee, S., Li, Y., Wang, Z., & Sarkar, F. H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.052 · Cited by 620
Butler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon‐Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2000) · PubMed · Cited by 615
Microtubules and actin filaments: dynamic targets for cancer chemotherapy
Jordan, M. A., & Wilson, L. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80095-1 · Cited by 614
Targeting telomeres and telomerase
De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., & Mergny, J.-L. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.011 · Cited by 572
Multi-targeted prevention of cancer by sulforaphane
Clarke, J. D., Dashwood, R. H., & Ho, E. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.018 · Cited by 563
The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds
Egan, D., O'kennedy, R., Moran, E., Cox, D., Prosser, E., & Thornes, R. D. (1990) · Drug Metabolism Reviews · doi:10.3109/03602539008991449 · Cited by 558
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
Pommier, Y., Pourquier, P., Fan, Y., & Strumberg, D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00129-8 · Cited by 551
A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Musa, M., Cooperwood, J., & Khan, M. O. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242877 · Cited by 538
A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease
Anand, P., Singh, B., & Singh, N. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.042 · Cited by 527
Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry
Whiting, M., Muldoon, J., Lin, Y., Silverman, S. M., Lindstrom, W., Olson, A. J., Kolb, H. C., Finn, M. G., Sharpless, K. B., Elder, J. H., et al. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502161 · Cited by 516
Natural Product Hybrids as New Leads for Drug Discovery
Tietze, L. F., Bell, H. P., & Chandrasekhar, S. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200553 · Cited by 516
Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
Solomon, V. R., & Lee, H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.063 · Cited by 516
Warner, E. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1101540 · Cited by 504
Manzamine A, a novel antitumor alkaloid from a sponge
Sakai, R., Higa, T., Jefford, C. W., & Bernardinelli, G. (1986) · Journal of the American Chemical Society · doi:10.1021/ja00280a055 · Cited by 482
Mortimer, C. G., Wells, G., Crochard, J.-P., Stone, E. L., Bradshaw, T. D., Stevens, M. F. G., & Westwell, A. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050942k · Cited by 475
Recent developments and biological activities of thiazolidinone derivatives: A review
Jain, A. K., Vaidya, A., Ravichandran, V., Kashaw, S. K., & Agrawal, R. K. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.069 · Cited by 461
From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
Giordano, S., & Petrelli, A. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783503212 · Cited by 457
Top, S., Vessières, A., Leclercq, G., Quivy, J. I., Tang, J., Vaissermann, J., Huché, M., & Jaouen, G. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200305024 · Cited by 454
Imidazole and Benzimidazole Derivatives as Chemotherapeutic Agents
Boiani, M., & Gonzalez, M. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557053544047 · Cited by 441
The structures of quadruplex nucleic acids and their drug complexes
Neidle, S. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.04.001 · Cited by 433
5-Fluorouracil: Forty-Plus and Still Ticking. A Review of its Preclinical and Clinical Development
Grem, J. L. (2000) · Investigational New Drugs · doi:10.1023/a:1006416410198 · Cited by 417
Aromatase, aromatase inhibitors, and breast cancer
Chumsri, S., Howes, T., Bao, T., Sabnis, G., & Brodie, A. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.02.001 · Cited by 401
Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance
Clarke, R., Leonessa, F., Welch, J. N., & Skaar, T. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01479-0 · Cited by 397
Jordan, V. C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020450x · Cited by 396
Gunasekera, S. P., Gunasekera, M., Longley, R. E., & Schulte, G. K. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00303a029 · Cited by 375
Shi, D.-F., Bradshaw, T. D., Wrigley, S., McCall, C. J., Lelieveld, P., Fichtner, I., & Stevens, M. F. G. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9600959 · Cited by 370
The binding conformation of Taxol in β-tubulin: A model based on electron crystallographic density
Snyder, J. P., Nettles, J. H., Cornett, B., Downing, K. H., & Nogales, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051309398 · Cited by 362
Etoposide (VP-16–213): Current Status of an Active Anticancer Drug
O'Dwyer, P. J., Leyland-Jones, B., Alonso, M. T., Marsoni, S., & Wittes, R. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121106 · Cited by 358
Estrogen receptor and breast cancer
Sommer, S., & Fuqua, S. A. W. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0389 · Cited by 355
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
Coley, H. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.007 · Cited by 351
Imbert, T. F. (1998) · Biochimie · doi:10.1016/s0300-9084(98)80004-7 · Cited by 350
The structural basis of camptothecin interactions with human serum albumin: impact on drug stability
Burke, T. G., & Mi, Z. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00027a005 · Cited by 331
Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer
Jordan, V. C., & O'Malley, B. W. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3886 · Cited by 324
Palakurthi, S. S., Aktaş, H., Grubissich, L., Mortensen, R. M., & Halperin, J. A. (2001) · PubMed · Cited by 302
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
Grant, C., Rahman, F., Piekarz, R., Peer, C., Frye, R., Robey, R. W., Gardner, E. R., Figg, W. D., & Bates, S. E. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.88 · Cited by 291
Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
casini, A., Scozzafava, A., Mastrolorenzo, A., & Supuran, C. (2002) · Current Cancer Drug Targets · doi:10.2174/1568009023334060 · Cited by 291
Synthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agents
Sashidhara, K. V., Kumar, A., Kumar, M., Sarkar, J., & Sinha, S. K. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.116 · Cited by 290
Messaoudi, S., Tréguier, B., Hamze, A., Provot, O., Peyrat, J.-F., De Losada, J. R., Liu, J.-M., Bignon, J., Wdzieczak-Bakala, J., Thoret, S., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900321u · Cited by 287
Naphthalimides as Anticancer Agents: Synthesis and Biological Activity
Brana, M., & Ramos, A. (2001) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011013354624 · Cited by 281
HANKA, L. J., DIETZ, A., GERPHEIDE, S. A., KUENTZEL, S. L., & MARTIN, D. G. (1978) · The Journal of Antibiotics · doi:10.7164/antibiotics.31.1211 · Cited by 272
Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines
Thurston, D. E., & Bose, D. S. (1994) · Chemical Reviews · doi:10.1021/cr00026a006 · Cited by 272
Shi, Y., & Zhou, C.-H. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.059 · Cited by 265
Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
Griffith, E. C., Su, Z., Niwayama, S., Ramsay, C. A., Chang, Y.-H., & Liu, J. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15183 · Cited by 262
CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
ALLEN, L. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.012 · Cited by 257
Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate.
Chaplin, D. J., Pettit, G. R., & Hill, S. A. (1999) · PubMed · Cited by 252
Haggarty, S. J., Mayer, T. U., Miyamoto, D. T., Fathi, R., King, R. W., Mitchison, T. J., & Schreiber, S. L. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00101-0 · Cited by 251
Tubulin and microtubules as targets for anticancer drugs.
Hadfield, J. A., Ducki, S., Hirst, N., & McGown, A. T. (2003) · PubMed · Cited by 247
Cárdenas, M., Marder, M., Blank, V. C., & Roguin, L. P. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.021 · Cited by 246
Past and future of the mitotic spindle as an oncology target
Wood, K. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00064-9 · Cited by 244
Antineoplastic Agents. 379. Synthesis of Phenstatin Phosphate1a,
Pettit, G. R., Toki, B. E., Herald, D. L., Verdier‐Pinard, P., Boyd, M. R., Hamel, E., & Pettit, R. K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970644q · Cited by 241
A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone
Prodromou, C., Roe, S. M., Piper, P. W., & Pearl, L. H. (1997) · Nature Structural Biology · doi:10.1038/nsb0697-477 · Cited by 239
Lamellarin D: a novel potent inhibitor of topoisomerase I.
Facompré, M., Tardy, C., Mahieu, C., Colson, P., Perez, C., Manzanares, I., Cuevas, C., & Bailly, C. (2003) · PubMed · Cited by 238
Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo
Carta, F., Aggarwal, M., Maresca, A., Scozzafava, A., McKenna, R., Masini, E., & Supuran, C. T. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300031j · Cited by 235
Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines (PBDs)
Antonow, D., & Thurston, D. E. (2011) · Chemical Reviews · doi:10.1021/cr100120f · Cited by 235
Pasquier, E., Ciccolini, J., Carre, M., Giacometti, S., Fanciullino, R., Pouchy, C., Montero, M.-P., Serdjebi, C., Kavallaris, M., & André, N. (2011) · Oncotarget · doi:10.18632/oncotarget.343 · Cited by 234
Taxol, a molecule for all seasons
Kingston, D. G. I. (2001) · Chemical Communications · doi:10.1039/b100070p · Cited by 233
Selective toxicity of rhodamine 123 in carcinoma cells in vitro.
Lampidis, T. J., Bernal, S. D., Summerhayes, I. C., & Chen, L. B. (1983) · PubMed · Cited by 233
Celecoxib: A Specific COX-2 Inhibitor with Anticancer Properties
Koki, A. T., & Masferrer, J. L. (2002) · Cancer Control · doi:10.1177/107327480200902s04 · Cited by 233
Belluti, F., Fontana, G., Bo, L. D., Carenini, N., Giommarelli, C., & Zunino, F. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.069 · Cited by 232
Stabilization of G-Quadruplex DNA by Highly Selective Ligands via Click Chemistry
Moorhouse, A. D., Santos, A. M., Gunaratnam, M., Moore, M., Neidle, S., & Moses, J. E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0661919 · Cited by 228
Promise and challenges in drug discovery and development of hybrid anticancer drugs
Gediya, L. K., & Njar, V. C. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903341705 · Cited by 222
Imidazole Alkaloids from Lepidium meyenii
Cui, B., Zheng, B. L., He, K., & Zheng, Q. Y. (2003) · Journal of Natural Products · doi:10.1021/np030031i · Cited by 221
Synthesis and Biological Evaluation of Resveratrol and Analogues as Apoptosis-Inducing Agents
Roberti, M., Pizzirani, D., Simoni, D., Rondanin, R., Baruchello, R., Bonora, C., Buscemi, F., Grimaudo, S., & Tolomeo, M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030785u · Cited by 216
Piazzi, L., Cavalli, A., Colizzi, F., Belluti, F., Bartolini, M., Mancini, F., Recanatini, M., Andrisano, V., & Rampa, A. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.100 · Cited by 214
The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties
Chadwick, L. R., Pauli, G. F., & Farnsworth, N. R. (2006) · Phytomedicine · doi:10.1016/j.phymed.2004.07.006 · Cited by 210
Khan, M. T. H., Choudhary, M. I., Khan, K. M., Rani, M., & Atta-ur-Rahman (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.03.012 · Cited by 210
Natural Products as a Source of Potential Cancer Chemotherapeutic and Chemopreventive Agents
Cassady, J. M., Baird, W. M., & Chang, C.-J. (1990) · Journal of Natural Products · doi:10.1021/np50067a003 · Cited by 208
Targeting tumour vasculature: the development of combretastatin A4
Griggs, J., Metcalfe, J. C., & Hesketh, R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00224-2 · Cited by 207
Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents
Luduena, R. F., & Roach, M. C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90027-j · Cited by 207
Gregson, S. J., Howard, P. W., Hartley, J. A., Brooks, N. A., Adams, L. J., Jenkins, T. C., Kelland, L. R., & Thurston, D. E. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001064n · Cited by 202
Tubulin structure: insights into microtubule properties and functions
Downing, K. H., & Nogales, E. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80099-7 · Cited by 201
Synthesis of new benzimidazole–coumarin conjugates as anti-hepatitis C virus agents
Hwu, J. R., Singha, R., Hong, S. C., Chang, Y. H., Das, A. R., Vliegen, I., De Clercq, E., & Neyts, J. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.09.003 · Cited by 200
Basis for the selective cytotoxicity of rhodamine 123.
Modica-Napolitano, J. S., & Aprille, J. R. (1987) · PubMed · Cited by 200
Cytotoxic pigments from new zealand sponges of the genus latrunculia : discorhabdins a, b and c
Perry, N. B., Blunt, J. W., & Munro, M. H. G. (1988) · Tetrahedron · doi:10.1016/s0040-4020(01)86737-5 · Cited by 199
MRI-Visible Micellar Nanomedicine for Targeted Drug Delivery to Lung Cancer Cells
Guthi, J. S., Yang, S.-G., Huang, G., Li, S., Khemtong, C., Kessinger, C. W., Peyton, M., Minna, J. D., Brown, K. C., & Gao, J. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9001393 · Cited by 197
Пили, Р., Chang, J., Partis, R. A., Mueller, R. A., Chrest, F. J., & Passaniti, A. (1995) · PubMed · Cited by 194
Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
Xia, Z., Knaak, C., Ma, J., Beharry, Z. M., McInnes, C., Wang, W., Kraft, A. S., & Smith, C. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800937p · Cited by 194
Kallander, L. S., Lu, Q., Chen, W., Tomaszek, T., Yang, G., Tew, D., Meek, T. D., Hofmann, G. A., Schulz-Pritchard, C. K., Smith, W. W., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050408c · Cited by 189
Cancer prevention research — then and now
Bode, A. M., & Dong, Z. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2646 · Cited by 188
Rinehart, K. L., Kobayashi, J., Harbour, G. C., Hughes, R. G., Mizsak, S. A., & Scahill, T. A. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00317a079 · Cited by 187
Mitotic drug targets and the development of novel anti-mitotic anticancer drugs
Schmidt, M., & Bastians, H. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.06.003 · Cited by 186
Glick, R. D., Swendeman, S. L., Coffey, D. C., Rifkind, R. A., Marks, P. A., Richon, V. M., & Quaglia, M. P. L. (1999) · PubMed · Cited by 185
Ohsumi, K., Hatanaka, T., Fujita, K., Nakagawa, R., Fukuda, Y., Nihei, Y., Suga, Y., Morinaga, Y., Akiyama, Y., & Tsuji, T. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00579-4 · Cited by 185
(2000) · PubMed · Cited by 181
Guimarães, C. R. W., Boger, D. L., & Jorgensen, W. L. (2005) · Journal of the American Chemical Society · doi:10.1021/ja055438j · Cited by 180
Imaging of Integrins as Biomarkers for Tumor Angiogenesis
Cai, W., Niu, G., & Chen, X. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404308 · Cited by 178
Rw, B., THOMSON, J. R., BELL, M. J., & He, S. (1956) · PubMed · Cited by 178
1,2,3-Triazole tethered β-lactam-Chalcone bifunctional hybrids: Synthesis and anticancer evaluation
Singh, P., Raj, R., Kumar, V., Mahajan, M. P., Bedi, P. M. S., Kaur, T., & Saxena, A. K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.10.033 · Cited by 177
Self-citationOrsini, F., Pelizzoni, F., Verotta, L., Aburjai, T., & Rogers, C. B. (1997) · Journal of Natural Products · doi:10.1021/np970069t · Cited by 174
Benzimidazole treatment of cystic echinococcosis
El-On, J. (2003) · Acta Tropica · doi:10.1016/s0001-706x(02)00217-6 · Cited by 172
Antineoplastic Agents. 465. Structural Modification of Resveratrol: Sodium Resverastatin Phosphate
Pettit, G. R., Grealish, M. P., Jung, M. K., Hamel, E., Pettit, R. K., Chapuis, J.-C., & Schmidt, J. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010119y · Cited by 172
Fascaplysin, an unusual antimicrobial pigment from the marine sponge Fascaplysinopsis sp
Roll, D. M., Ireland, C. M., Lu, H. S. M., & Clardy, J. (1988) · The Journal of Organic Chemistry · doi:10.1021/jo00249a025 · Cited by 171
Overmeyer, J. H., Young, A. M., Bhanot, H., & Maltese, W. A. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-69 · Cited by 171
El-Sayed, M. A.-A., Abdel-Aziz, N. I., Abdel-Aziz, A. A.-M., El-Azab, A. S., Asiri, Y. A., & ElTahir, K. E. H. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.027 · Cited by 170
Clotrimazole inhibits cell proliferation in vitro and in vivo
Benzaquen, L. R., Brugnara, C., Byers, H. R., Gattoni-Celli, S., & Halperin, J. A. (1995) · Nature Medicine · doi:10.1038/nm0695-534 · Cited by 166
Hurley, L. H. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.349 · Cited by 166
Breast Cancer, Estrogen Receptor and Ligands
Bai, Z., & Gust, R. (2009) · Archiv der Pharmazie · doi:10.1002/ardp.200800174 · Cited by 165
Estrogen receptor β ligands: Recent advances and biomedical applications
Minutolo, F., Macchia, M., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2009) · Medicinal Research Reviews · doi:10.1002/med.20186 · Cited by 165
Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity
Reddy, N. S., Mallireddigari, M. R., Cosenza, S., Gumireddy, K., Bell, S. C., Reddy, E. P., & Reddy, M. V. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.05.016 · Cited by 165
Kohlhagen, G., Paull, K. D., Cushman, M., Nagafuji, P., & Pommier, Y. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.50 · Cited by 165
The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives
Pommier, Y., & Cushman, M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0706 · Cited by 161
Cancer Cell Mitochondria Are Direct Proapoptotic Targets for the Marine Antitumor Drug Lamellarin D
Kluza, J., Gallego, M.-A., Loyens, A., Beauvillain, J.-C., Sousa-Faro, J.-M. F., Cuevas, C., Marchetti, P., & Bailly, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1929 · Cited by 160
Azidonucleosides: Synthesis, Reactions, and Biological Properties
Pathak, T. (2002) · Chemical Reviews · doi:10.1021/cr0104532 · Cited by 160
Selectively targeting estrogen receptors for cancer treatment
Shanle, E. K., & Xu, W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.001 · Cited by 158
Hulsman, N., Medema, J. P., Bos, C. L., Jongejan, A., Leurs, R., Smit, M. J., de Esch, I. J. P., Richel, D. J., & Wijtmans, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061371e · Cited by 157
Localization of the colchicine-binding site of tubulin.
Uppuluri, S., Knipling, L., Sackett, D. L., & Wolff, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11598 · Cited by 157
Loike, J. D., Brewer, C. F., Sternlicht, H., Gensler, W. J., & Horwitz, S. B. (1978) · PubMed · Cited by 156
Trapp, J., Jochum, A., Meier, R., Saunders, L. R., Marshall, B. L., Kunick, C., Verdin, E. M., Goekjian, P. G., Sippl, W., & Jung, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060118b · Cited by 153
Colchicine and its analogues: Recent findings
Brossi, A. R., Yeh, H. J. C., Chrzanowska, M., Wolff, J., Hamel, E., Lin, C. M., Quinn, F. R., Suffness, M., & Silverton, J. V. (1988) · Medicinal Research Reviews · doi:10.1002/med.2610080105 · Cited by 153
Fujimori, A., Harker, W. G., Kohlhagen, G., Hoki, Y., & Pommier, Y. G. (1995) · PubMed · Cited by 151
Jain, T. K., Foy, S. P., Erokwu, B. O., Dimitrijevic, S., Flask, C. A., & Labhasetwar, V. D. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.042 · Cited by 148
Increased rhodamine 123 uptake by carcinoma cells.
Nadakavukaren, K. K., Nadakavukaren, J. J., & Chen, L. B. (1985) · PubMed · Cited by 147
Pluramycins. Old Drugs Having Modern Friends in Structural Biology
Hansen, M. R., & Hurley, L. H. (1996) · Accounts of Chemical Research · doi:10.1021/ar950167a · Cited by 147
A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells.
Lane, M. E., Yu, B., Rice, A. G., Lipson, K. E., Liang, C., Sun, L., Tang, C., McMahon, G., Pestell, R. G., & Wadler, S. (2001) · PubMed · Cited by 145
Bose, D. S., & Idrees, M. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo0609374 · Cited by 141
The reemergence of nitric oxide and cancer
Wink, D. A., Ridnour, L. A., Hussain, S. P., & Harris, C. C. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.05.003 · Cited by 140
The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4
Flynn, B. L., Flynn, G. P., Hamel, E., & Jung, M. K. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00436-x · Cited by 140
Manley, P. W., Bold, G., Brüggen, J., Fendrich, G., Furet, P., Mestan, J., Schnell, C., Stolz, B., Meyer, T., Meyhack, B., et al. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.010 · Cited by 136
Bose, D. S., Thompson, A. S., Ching, J., Hartley, J. A., Berardini, M. D., Jenkins, T. C., Neidle, S., Hurley, L. H., & Thurston, D. E. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00038a089 · Cited by 136
Andrzejewska, M. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(02)01421-6 · Cited by 136
Solomon, V. R., Hu, C., & Lee, H. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.001 · Cited by 135
Kashfi, K., Rayyan, Y. M., QIAO, L., Williams, J. L., Chen, J., Soldato, P. D., Traganos, F., & Rigas, B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042754 · Cited by 134
Maragos, C. M., Wang, J., Hrabie, J. A., Oppenheim, J. J., & Keefer, L. K. (1993) · PubMed · Cited by 132
Antony, S., Agama, K., Miao, Z., Takagi, K., Wright, M. H., Robles, A. I., Varticovski, L., Nagarajan, M., Morrell, A. E., Cushman, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0938 · Cited by 132
West, C., & Price, P. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200403000-00001 · Cited by 129
Chattopadhyay, M., Kodela, R., Olson, K. R., & Kashfi, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.051 · Cited by 127
Lv, P., Zhou, C., Chen, J., Liu, P., Wang, K., Mao, W., Li, H., Yang, Y., Xiong, J., & Zhu, H. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.051 · Cited by 127
Boger, D. L., Yasuda, M., Mitscher, L. A., Drake, S. D., Kitos, P. A., & Thompson, S. C. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00393a040 · Cited by 126
Kamal, Ä., Reddy, K. S., Khan, M. N. A., Shetti, R. V. C. R. N. C., Ramaiah, M. J., Pushpavalli, S. N. C. V. L., Chatla, S., Pal‐Bhadra, M., Chourasia, M., Sastry, G. N., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.007 · Cited by 123
Thiol-Dependent Enzymes and Their Inhibitors: A Review
Leung-Toung, R., Li, W., Tam, T. F., et al. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606704 · Cited by 123
Baselga, J. M., & Norton, L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00066-1 · Cited by 122
Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative
Devji, T. F., Reddy, C., Woo, C. M., Awale, S., Kadota, S., & Carrico-Moniz, D. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.005 · Cited by 121
Whang, W. K., Park, H. S., Ham, I., Oh, M., Namkoong, H., Kim, H. K., Hwang, D. W., Hur, S. Y., Kim, T. E., Park, Y. G., et al. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.54 · Cited by 120
Caulerpenyne, an unusual sequiterpenoid from the green alga caulerpa prolifera
Amico, V., Oriente, G., Piattelli, M., Tringali, C., Fattorusso, E., Magno, S., & Mayol, L. (1978) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)95003-8 · Cited by 119
Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells
Türk, D., Hall, M. D., Chu, B. F., Ludwig, J. A., Fales, H. M., Gottesman, M. M., & Szakács, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2422 · Cited by 118
Modulation of camptothecin analogs in the treatment of cancer: a review
Kehrer, D. F. S., Soepenberg, O., Loos, W. J., Verweij, J., & Sparreboom, A. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200102000-00002 · Cited by 117
Hickey, K., Grehan, D., Reid, L. M., O’Briain, S., Walsh, T. N., & Hennessy, T. P. J. (1994) · Cancer · doi:10.1002/1097-0142(19940915)74:6<1693::aid-cncr2820740609>3.0.co;2-# · Cited by 117
The Microtubule Stabilizing Agent Discodermolide is a Potent Inducer of Accelerated Cell Senescence
Klein, L. E., Freeze, B. S., Smith, A. B., & Horwitz, S. B. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1550 · Cited by 116
Thurston, D. E., Bose, D. S., Thompson, A. S., Howard, P. W., Leoni, A., Croker, S. J., Jenkins, T. C., Neidle, S., Hartley, J. A., & Hurley, L. H. (1996) · The Journal of Organic Chemistry · doi:10.1021/jo951631s · Cited by 116
Lai, Z., Yang, T., Kim, Y. B., Sielecki, T. M., Diamond, M. A., Strack, P. R., Rolfe, M., Caligiuri, M., Benfield, P. A., Auger, K. R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212428599 · Cited by 115
Palakurthi, S. S., Flückiger, R., Aktas, H., Changolkar, A. K., Shahsafaei, A., Harneit, S., Kilic, E., & Halperin, J. A. (2000) · PubMed · Cited by 114
Interaction of vinblastine with steady-state microtubules in vitro
Wilson, L., Jordan, M. A., Morse, A. N. C., & Margolis, R. L. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90035-3 · Cited by 113
Kirkegaard, T., McGlynn, L. M., Campbell, F., Müller, S., Tovey, S., Dunne, B., Nielsen, K. V., Cooke, T. G., & Bartlett, J. M. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1933 · Cited by 112
Barbier, P., Guise, S., Huitorel, P., Amade, P., Pesando, D., Briand, C., & Peyrot, V. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01396-0 · Cited by 110
Synthesis and evaluation of geldanamycin-estradiol hybrids
Kuduk, S. D., Zheng, F. F., Sepp‐Lorenzino, L., Rosen, N. X., & Danishefsky, S. J. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00185-7 · Cited by 109
DNA cleavage assay for the identification of topoisomerase I inhibitors
Dexheimer, T. S., & Pommier, Y. G. (2008) · Nature Protocols · doi:10.1038/nprot.2008.174 · Cited by 109
Đạt, N. T., Jin, X., Lee, K., Hong, Y., Kim, Y. H., & Lee, J. J. (2008) · Journal of Natural Products · doi:10.1021/np800491u · Cited by 108
Translation initiation in cancer: a novel target for therapy.
Meric, F., & Hunt, K. K. (2002) · PubMed · Cited by 108
Shami, P. J., Saavedra, J. E., Bonifant, C. L., Chu, J., Udupi, V., Malaviya, S., Carr, B. I., Kar, S., Wang, M., Jia, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060022h · Cited by 107
Biological/Chemopreventive Activity of Stilbenes and their Effect on Colon Cancer
Rimando, A. M., & Suh, N. (2008) · Planta Medica · doi:10.1055/s-0028-1088301 · Cited by 107
Cytotoxic Pyrroloiminoquinones from Four New Species of South African Latrunculid Sponges
Antunes, E. M., Beukes, D. R., Kelly, M., Samaai, T., Barrows, L. R., Marshall, K. M., Sincich, C., & Davies‐Coleman, M. T. (2004) · Journal of Natural Products · doi:10.1021/np034084b · Cited by 106
Tubulin/Microtubules: Still a Promising Target for New Chemotherapeutic Agents
Giannakakou, P., Sackett, D. L., & Fojo, T. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.182 · Cited by 105
Cited by
Hybrid molecules: The privileged scaffolds for various pharmaceuticals
Shaveta, Mishra, S., & Singh, P. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.039 · Cited by 508
An overview of molecular hybrids in drug discovery
Bérubé, G. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1135125 · Cited by 338
1,2,3‐Triazole hybrids as anticancer agents: A review
Alam, M. M. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202100158 · Cited by 312
Metadata
- Authors
- Nepali, K., Sharma, S., Sharma, M., Bedi, P. M. S., & Dhar, K. L.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 77
- Pages
- 422-487
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2951185063
- Cited by
- 435
- References
- 307
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.